Receptor-interacting protein kinase 1 (RIPK1) polyubiquitination by IAPs has been shown to promote cytoprotection and cell survival in cancer cells via NF-κB activation (Pedersen et al., 2014). The gene discussed is NFKB1; the disease is cancer.